Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis
- PMID: 16841629
- DOI: 10.4088/jcp.v67n0513
Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis
Abstract
Objective: Clozapine and olanzapine treatment has been associated with insulin resistance in non-obese schizophrenia patients. Much less is known regarding other agents such as quetiapine. The objective of this study was to compare matched olanzapine- and quetiapine-treated schizophrenia patients and normal controls on measures of glucose metabolism.
Method: A cross-sectional comparison of quetiapine-treated and olanzapine-treated non-obese (body mass index < 30.0 kg/m2) schizophrenia subjects (DSM-IV) with matched normal controls using a frequently sampled intravenous glucose tolerance test and nutritional assessment was conducted from April 2002 to October 2004. Data from 24 subjects were included in the analysis (7 quetiapine, 8 olanzapine, 9 normal controls).
Results: There was a significant difference among groups for fasting baseline plasma glucose concentrations (p = .02), with olanzapine greater than normal controls (p = .01). The insulin sensitivity index (SI) differed significantly among groups (p = .039); olanzapine subjects exhibited significant insulin resistance compared to normal controls (p = .01), but there was no significant difference for quetiapine versus olanzapine (p = .1) or quetiapine versus normal controls (p = .40). SI inversely correlated with quetiapine dose (p = .0001) and waist circumference (p = .03) in quetiapine-treated subjects. Insulin resistance calculated by the homeostasis model assessment of insulin resistance (HOMA-IR) also differed significantly among groups (p = .03). The olanzapine group had a higher HOMA-IR level than normal controls (p = .01). There was a significant difference in glucose effectiveness (SG) among the groups (p = .049). SG was lower in the olanzapine group than in the quetiapine group (p = .03) and in the olanzapine group compared to normal controls (p = .049).
Conclusions: Our findings are consistent with our previous report that nonobese olanzapine-treated subjects showed insulin resistance, measured by both HOMA-IR and SI, and reduction in SG. Studies that include larger samples, unmedicated patients, and varying durations of antipsychotic exposure are necessary to confirm these results.
Comment in
-
What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?J Clin Psychiatry. 2007 May;68(5):799-800; author reply 801-2. doi: 10.4088/jcp.v68n0522c. J Clin Psychiatry. 2007. PMID: 17503995 No abstract available.
-
What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?J Clin Psychiatry. 2007 May;68(5):800-1; author reply 801-2. doi: 10.4088/jcp.v68n0522d. J Clin Psychiatry. 2007. PMID: 17508432 No abstract available.
Similar articles
-
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.J Psychiatr Pract. 2009 Jul;15(4):251-61. doi: 10.1097/01.pra.0000358312.99233.ef. J Psychiatr Pract. 2009. PMID: 19625881 Free PMC article.
-
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.Arch Gen Psychiatry. 2005 Jan;62(1):19-28. doi: 10.1001/archpsyc.62.1.19. Arch Gen Psychiatry. 2005. PMID: 15630069
-
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.J Clin Psychiatry. 2009 Apr;70(4):487-99. doi: 10.4088/jcp.08m04132. Epub 2009 Apr 7. J Clin Psychiatry. 2009. PMID: 19358783 Free PMC article. Clinical Trial.
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
-
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.Curr Med Chem. 2004 Feb;11(3):279-96. doi: 10.2174/0929867043456089. Curr Med Chem. 2004. PMID: 14965232 Review.
Cited by
-
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.Acta Psychiatr Scand. 2009 Jun;119(6):457-65. doi: 10.1111/j.1600-0447.2008.01325.x. Epub 2009 Jan 12. Acta Psychiatr Scand. 2009. PMID: 19183127 Free PMC article. Clinical Trial.
-
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.J Clin Psychopharmacol. 2009 Apr;29(2):165-9. doi: 10.1097/JCP.0b013e31819a8dbe. J Clin Psychopharmacol. 2009. PMID: 19512978 Free PMC article. Clinical Trial.
-
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.J Psychiatr Pract. 2009 Jul;15(4):251-61. doi: 10.1097/01.pra.0000358312.99233.ef. J Psychiatr Pract. 2009. PMID: 19625881 Free PMC article.
-
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.Schizophr Res. 2008 Apr;101(1-3):273-86. doi: 10.1016/j.schres.2007.12.487. Epub 2008 Feb 6. Schizophr Res. 2008. PMID: 18258416 Free PMC article. Clinical Trial.
-
A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.PLoS One. 2011;6(8):e22662. doi: 10.1371/journal.pone.0022662. Epub 2011 Aug 9. PLoS One. 2011. PMID: 21857944 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous